CirChem AB (publ) Logo

CirChem AB (publ)

CIRCHE.ST

(1.5)
Stock Price

3,16 SEK

-19.68% ROA

-34.06% ROE

-6.69x PER

Market Cap.

83.840.306,00 SEK

20.98% DER

0% Yield

-142.61% NPM

CirChem AB (publ) Stock Analysis

CirChem AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CirChem AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 PBV

The stock's PBV ratio (2.04x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

4 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-66.91%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-43.08%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

CirChem AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CirChem AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

CirChem AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CirChem AB (publ) Revenue
Year Revenue Growth
2017 0
2018 167.726 100%
2019 18.770 -793.59%
2020 73.198 74.36%
2021 85.553 14.44%
2022 590.615 85.51%
2023 2.772.000 78.69%
2023 5.745.000 51.75%
2024 5.932.000 3.15%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CirChem AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CirChem AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 435.523
2018 952.791 54.29%
2019 1.810.202 47.37%
2020 8.942.189 79.76%
2021 14.807.344 39.61%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CirChem AB (publ) EBITDA
Year EBITDA Growth
2017 -435.928
2018 -791.289 44.91%
2019 -1.789.449 55.78%
2020 -8.850.427 79.78%
2021 -16.736.271 47.12%
2022 -19.871.749 15.78%
2023 -13.876.000 -43.21%
2023 -15.682.000 11.52%
2024 -11.612.000 -35.05%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CirChem AB (publ) Gross Profit
Year Gross Profit Growth
2017 0
2018 162.366 100%
2019 -1.338.867 112.13%
2020 2.155.778 162.11%
2021 2.617.275 17.63%
2022 2.921.542 10.41%
2023 1.320.000 -121.33%
2023 -15.732.000 108.39%
2024 -11.776.000 -33.59%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CirChem AB (publ) Net Profit
Year Net Profit Growth
2017 -525.893
2018 -1.213.966 56.68%
2019 -4.652.163 73.91%
2020 -10.038.513 53.66%
2021 -19.481.907 48.47%
2022 -25.499.027 23.6%
2023 -14.848.000 -71.73%
2023 -17.141.000 13.38%
2024 -11.064.000 -54.93%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CirChem AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 0
2018 0 0%
2019 0 0%
2020 -1 0%
2021 -1 100%
2022 -1 0%
2023 -1 0%
2023 -1 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CirChem AB (publ) Free Cashflow
Year Free Cashflow Growth
2017 0
2018 -9.977.000 100%
2019 -26.045.100 61.69%
2020 -1.577.623 -1550.91%
2021 -5.466.513 71.14%
2022 -25.265.461 78.36%
2023 -27.481.000 8.06%
2023 -1.337.000 -1955.42%
2024 -7.206.000 81.45%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CirChem AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2017 0
2018 307.600 100%
2019 -13.553.600 102.27%
2020 2.268.875 697.37%
2021 -2.777.052 181.7%
2022 -21.485.510 87.07%
2023 -26.683.000 19.48%
2023 -1.308.000 -1939.98%
2024 -5.070.000 74.2%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CirChem AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2017 0
2018 10.284.600 100%
2019 12.491.500 17.67%
2020 3.846.498 -224.75%
2021 2.689.461 -43.02%
2022 3.779.951 28.85%
2023 798.000 -373.68%
2023 29.000 -2651.72%
2024 2.136.000 98.64%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CirChem AB (publ) Equity
Year Equity Growth
2017 4.907.901
2018 8.253.255 40.53%
2019 32.533.048 74.63%
2020 44.523.449 26.93%
2021 26.372.993 -68.82%
2022 25.127.915 -4.95%
2023 36.927.000 31.95%
2023 35.105.000 -5.19%
2024 33.965.000 -3.36%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CirChem AB (publ) Assets
Year Assets Growth
2017 8.346.051
2018 21.685.584 61.51%
2019 44.643.418 51.42%
2020 56.991.860 21.67%
2021 52.143.429 -9.3%
2022 50.302.779 -3.66%
2023 60.108.000 16.31%
2023 59.109.000 -1.69%
2024 59.593.000 0.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CirChem AB (publ) Liabilities
Year Liabilities Growth
2017 3.438.150
2018 13.432.329 74.4%
2019 12.110.370 -10.92%
2020 12.468.411 2.87%
2021 25.770.436 51.62%
2022 25.174.864 -2.37%
2023 23.181.000 -8.6%
2023 24.005.000 3.43%
2024 25.628.000 6.33%

CirChem AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.28
Net Income per Share
-0.4
Price to Earning Ratio
-6.69x
Price To Sales Ratio
10.2x
POCF Ratio
-5.98
PFCF Ratio
-5.03
Price to Book Ratio
2.31
EV to Sales
9.36
EV Over EBITDA
-6.95
EV to Operating CashFlow
-5.86
EV to FreeCashFlow
-4.61
Earnings Yield
-0.15
FreeCashFlow Yield
-0.2
Market Cap
0,08 Bil.
Enterprise Value
0,08 Bil.
Graham Number
3.24
Graham NetNet
-0.35

Income Statement Metrics

Net Income per Share
-0.4
Income Quality
1.15
ROE
-0.34
Return On Assets
-0.2
Return On Capital Employed
-0.27
Net Income per EBT
1
EBT Per Ebit
1.05
Ebit per Revenue
-1.36
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.3
Operating Profit Margin
-1.36
Pretax Profit Margin
-1.43
Net Profit Margin
-1.43

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.45
Free CashFlow per Share
-0.57
Capex to Operating CashFlow
-0.27
Capex to Revenue
0.43
Capex to Depreciation
34.37
Return on Invested Capital
-0.27
Return on Tangible Assets
-0.2
Days Sales Outstanding
80.93
Days Payables Outstanding
90.05
Days of Inventory on Hand
10.26
Receivables Turnover
4.51
Payables Turnover
4.05
Inventory Turnover
35.59
Capex per Share
0.12

Balance Sheet

Cash per Share
0,48
Book Value per Share
1,16
Tangible Book Value per Share
1.16
Shareholders Equity per Share
1.16
Interest Debt per Share
0.28
Debt to Equity
0.21
Debt to Assets
0.12
Net Debt to EBITDA
0.62
Current Ratio
0.89
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
41092000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
161500
Debt to Market Cap
0.09

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CirChem AB (publ) Dividends
Year Dividends Growth

CirChem AB (publ) Profile

About CirChem AB (publ)

CirChem AB (publ) engages in recycling of used solvents in Sweden. It collects and purify used industrial solvents for reuse; and produces other chemical products, such as washer fluid and rubbing alcohol. CirChem AB (publ)was founded in 2013 and is based in Vargon, Sweden.

CEO
Mr. Kristofer Svensson
Employee
13
Address
MAelderistvAegen 3
Vargön, 468 30

CirChem AB (publ) Executives & BODs

CirChem AB (publ) Executives & BODs
# Name Age
1 Mr. Kristofer Svensson
Chief Financial Officer
70

CirChem AB (publ) Competitors